Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Molecular Tumor Board, Biliary Rare Cancers

Lipika Goyal

MD, MPhil

🏢Stanford University Medical Center🌐USA

Assistant Professor of Medicine

39
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Dr. Lipika Goyal is a GI oncologist at Stanford specializing in biliary tract cancers and molecular tumor board practice. She has contributed to establishing FGFR2 inhibitors and IDH1 inhibitors as standard options for cholangiocarcinoma through clinical trials including FIGHT-202 and ClarIDHy. Her work on molecular profiling of rare biliary tumors informs molecular tumor board practice for uncommon GI malignancies.

Share:

🧪Research Fields 研究领域

FGFR2 fusion cholangiocarcinoma
IDH1 mutation bile duct cancer
biliary tract cancer molecular profiling
TAPUR rare cancer cohorts
molecular tumor board GI rare tumors

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Lipika Goyal 的研究动态

Follow Lipika Goyal's research updates

留下邮箱,当我们发布与 Lipika Goyal(Stanford University Medical Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment